zilretta
Generic: triamcinolone acetonide
zilretta: developed by 2 companies · 1 clinical trial tracked.
zilretta evidence translation
What we can confirm
1 tracked trial
What it means
More than one developer is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about zilretta, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
osteoarthritis knee painGlenohumeral Osteoarthritis
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (2)
| Company | Phase |
|---|---|
| Flexion Therapeutics Inc (FLXN) osteoarthritis knee pain | Approved |
| Pacira BioSciences, Inc. (PCRX) Glenohumeral Osteoarthritis | Approved |
Clinical Trials (1)
A Study to Evaluate the Efficacy and Safety of ZILRETTA in Subjects With Glenohumeral Osteoarthritis
Primary endpoint: Change from Baseline on the Worst Daily Pain (24-hr) mean score (0-10 Numeric Rating Scale (NRS); 0 = no pain, 10 = worst possible pain) at Week 12 for ZILRETTA relative to placebo
InterventionalRandomizedsingle150 targetStarted 2024-02Completion 2026-1232 sites · United StatesPacira Pharmaceuticals, Inc
Frequently asked questions
Who is developing zilretta?
zilretta is being developed by Flexion Therapeutics Inc, Pacira BioSciences, Inc..
How many clinical trials involve zilretta?
BioSniper tracks 1 clinical trial involving zilretta.